Microbial Sinus Dynamics In Cystic Fibrosis Lung Transplant Patients

Microbial Sinus Dynamics In Cystic Fibrosis Lung Transplant Patients The upper airways in individuals with cystic fibrosis (PwCF) are constantly exposed to inhaled microbes. The sinonasal cavity is identified as the initial site colonized by pathogenic microbes with the potential to impact the lower respiratory tract. Chronic rhinosinusitis (C.R.S.), a prevalent

Tislelizumab Treatment And Quality Of Life In Lung Cancer Patients

Tislelizumab Treatment And Quality Of Life In Lung Cancer Patients Overview In the Phase 3 trial RATIONALE-303 (NCT03358875), the study evaluated the health-related quality of life (HRQoL) among patients with advanced non-small cell lung cancer (NSCLC) who were treated with either tislelizumab or docetaxel. The assessment utilized three measurement instruments: EORTC QLQ-C30,

Microbial Sinus Dynamics In Cystic Fibrosis Lung Transplant Patients